Company Filing History:
Years Active: 2014-2022
Title: Lubov Konstantinovna Filonova: Innovator in Adenosine Receptor Modulation
Introduction
Lubov Konstantinovna Filonova is a prominent inventor based in Redwood City, CA (US). She has made significant contributions to the field of pharmacology, particularly in the modulation of adenosine receptors. With a total of 2 patents, her work has implications for various therapeutic applications.
Latest Patents
Her latest patents include "Compounds and methods for modulating adenosine A2B receptor and adenosine A2A receptor." This patent discloses certain substituted thieno[3,2-b]pyrimidine compositions and methods for modulating adenosine receptors. Another notable patent is "Inhibitors of JNK - Compounds of formula I," which focuses on innovative compounds that can inhibit specific pathways in cellular processes.
Career Highlights
Throughout her career, Lubov has worked with notable companies such as Corvus Pharmaceuticals, Inc. and Roche Palo Alto LLC. Her experience in these organizations has allowed her to develop and refine her expertise in drug development and receptor modulation.
Collaborations
Lubov has collaborated with esteemed colleagues, including Zhihong Li and Erin Kathleen Bradley. These partnerships have contributed to her innovative research and the successful development of her patented technologies.
Conclusion
Lubov Konstantinovna Filonova is a distinguished inventor whose work in adenosine receptor modulation has the potential to advance therapeutic strategies. Her contributions to the field are noteworthy and continue to influence research and development in pharmacology.